Pharmaceuticals
AstraZeneca cancer drug fails trail, shares drop
The Anglo-Swedish drugmaker's cancer drug Recentin failed in a one on one late stage trial with Roche's Avastin in colorectal cancer patients….
Changes in Canadian Tax law open doors for U.S. investment in Canadian biotech
Changes to section 116 will remove double tax filing requirements and administrative delays that turned invertors away from Canadian biotech firms…
Bristol-Myers Squibb announces new CEO and quarterly dividends
The global biopharmaceutical company declared quarterly dividends and named Lamberto Andreotti CEO effective May 4...
Shire plc Supports Rare Disease Day 2010
The British biopharmaceutical company announced that it will create media coverage in many countries to raise awareness and understanding of rare diseases…
Novartis’ cancer drug wins FDA priority review
Tasigna receives U.S. Food and Drug Administration priority review for newly diagnosed patients with early-stage chronic myeloid leukemia...
Walgreens to purchase New York City’s largest drug store chain
Walgreens is set acquire Duane Reade and take leadership position in the United State’s largest retail and drugstore market...
Teva Pharmaceutical Industries Ltd reports record full year and fourth quarter results
The generic drug giant reported record annual sales in all geographies…
ReNeuron approved to begin landmark clinical trial for stroke victims
The UK Gene Therapy Advisory Committee has approved ReNeuron’s first-in-man clinical trial to determine whether stem cell therapy can help stroke patients…
Pfizer reports high 4Q Earnings following Wyeth merger
Pfizer Inc.’s profits were boosted by its merger with rival Wyeth and the absence of last years high charges due to investigations…
Abbott and Pierre Fabre SA team to develop cancer treatments
US and French healthcare companies agree to jointly develop and commercialize h224G11, a pre-clinical monoclonal antibody…
Gates Foundation Pledges $10 billion for vaccines
Bill and Melinda Gates announced that a commitment to research could save more than 8 million children by 2020…
Bristol, Eli Lilly post fourth quarter profits; AstraZeneca to cut 8,000 jobs
Bristol-Myers Squibb Co. and Eli Lilly & Co. saw fourth-quarter revenue increases, while AstraZeneca PLC plans to cut 8,000 more jobs by 2014 to cut costs as it reported weak earnings...
Teva Pharmaceuticals updates strategy to reach $31 billion in revenue by 2015
Strategy highlights key opportunities for growth and announces long-term goals...
Clinical trial begins in AstraZeneca, Merck & Co. partnership
San Antonio-Based South Texas Accelerated Research Therapeutics is the First Site to Test Combination Anticancer Regimen…
Soligenix, Inc publishes characteristics of ricin A chain
The article details the antigenic component of RiVax™, a vaccine to protect against exposure to ricin toxin…
Sanofi-Aventis S.A. to acquire Chattem Inc for $1.9 billion
The cash deal would create world's fifth-largest consumer health-care company…
High cost of healthcare impacting holiday spending
New survey indicates that two in five Americans plan to spend less this holiday season as a result of rising health care costs…
Allergy fears halt distribution of GlaxoSmithKline swine flu vaccine in Canada
GlaxoSmithKline PLC advised healthcare workers in Canada not to use one batch of swine flu vaccine because of possible life-threatening allergies…
Quit Smoking: With a Vaccine?
Nabi Biopharmaceuticals and GlaxoSmithKline team up to produce nicotine vaccine and help smokers kick the habit…
Mead Johnson Nutrition Company to split off Bristol-Myers Squibb
Bristol-Myers Squibb Company announced it will split off its holdings in Mead Johnson Nutrition Company…
Pharmaceutical companies want more online ads
Pfizer, Eli Lilly and other pharmaceutical giants head to Washington DC to get advertising guidelines from the FDA...
Glaxo wins FDA approval to sell swine flu vaccine in US
GlaxoSmithKline Plc has won US marketing approval for its unadjuvanted H1N1 swine flu vaccine…
Johnson & Johnson to cut 7,000 jobs
Johnson & Johnson, the world's largest healthcare company, will generate up to $1.7 billion in pretax cost savings through job cuts and other means…
Wall Street Receives Swine Flu Vaccine ahead of hospitals
Wall Street giants Goldman Sachs and Citigroup among others received doses of swine flu vaccine; critics say vaccine going to the privileged first…
Human Genome Sciences Inc and Glaxo developed lupus drug works in 2nd trial
Benlysta was successful in a second large clinical trial...
Merck & Co., Inc and Schering-Plough Corporation Receive Merger Approvals
The Swiss Competition Commission, U.S. Federal Trade Commission, and Canadian Competition Bureau approve Merck and Schering-Plough merger...
Bill and Melinda Gates call for more US aid for global health
Global Health is 'America's Best Investment for Saving Lives' they said…
Pfizer acquires Wyeth
Today Pfizer has combined operations with Wyeth following the closing of the acquisition yesterday…
Developing nations receive donated Swine Flu vaccine
Pharmaceutical companies and rich nations pledge to donate…
Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
Contribution to overall drug spending hit five percent in 2009…
Swine Flu Vaccine is safe says WHO
Mass vaccination campaigns are underway in China, Australia, and US...
Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)
Carbidopa and Levodopa Tablets approved today...
Trial gives new hope for AIDS vaccine
Combo vaccine to prevent HIV infection has shown modest results...
Using Social Media in Pharmaceutical eMarketing
How to Use It Effectively, Meet the Challenges, and Measure Results in Dollar Terms…
Dainippon Sumitomo to Acquire Sepracor for $2.6 Billion
Sepracor provides Dainippon Sumitomo door into U.S. market
China may Approve 1-dose Swine Flu Vaccine
Chinese developed swine flu vaccines may protect with only one dose
AstraZeneca’s new clot-fighting drug Brilinta beats Plavix
In study, Brilinta prevented 16 percent more heart attacks, strokes and deaths than standard therapy with Plavix
Tobacco may yield vaccine for stomach virus
Researchers believe plants may produce vaccine again norovirus
US FDA approves Extavia
Novartis says drug is first in a new portfolio of planned MS therapies
Researchers soon to begin human trials of genetically-engineered malaria vaccine
The Walter and Eliza Hall Institute in Melbourne, Australia has created a weakened strain of the malaria parasite
Swine Flu vaccine may be ready in month
WHO says first vaccines to combat H1N1 should be approved and ready in September
Novartis begins human testing of swine flu vaccine
The Swiss drug manufacturer begins yearlong trial of H1N1 vaccine
Biotivia Bioceuticals hopes for successful UK product launch
BioFlu, an immune system boosting supplement, will soon be available in the UK
FDA approves first and only treatment for Schizoaffective Disorder
INVEGA(R) approved for use as monotherapy or adjunctive therapy
Mosquitoes’ bites used to deliver malaria “vaccine”
Scientists in Europe used mosquitoes as airborne needles to carry a "vaccine" of live malaria parasites
Indian pharmaceutical company eyes Japan’s generics market
Nippon Universal Pharmaceutical Co. Ltd. is hoping to enhance its operations in Japan’s still growing generics market
Australian company tests out potential H1N1 vaccine
As the Swine Flu continues to spread, Melbourne based CSL Ltd. will test the potential first H1N1 vaccine on humans
Hisamitsu to buy Noven Pharma for $428 million
Japanese firm buys out Miami pharmaceutical company through a definitive merger agreement
FDA advisers look to restrict acetaminophen
Advisory groups recommend the FDA to restrict the over-the-counter dosage of acetaminophen - the main ingredient in many pain killing medications.
GSK teams up with Dr. Reddy's
The two global pharmaceutical companies enter a strategic alliance for emerging markets
Mayoly Spindler and Protea enter drug development partnership
The US and European based companies will collaborate in the development of a new biopharmaceutical for the treatment of exocrine pancreatic insufficiency
FDA approves first ever canine cancer treatment
Pfizer's PALLADIATM (toceranib phosphate), the first ever canine cancer therapy has been approved by the FDA
Pfizer aligns with two Indian-based companies
The world's largest drugmaker seeks new avenues of growth in generics and emerging markets
Sciele Pharma acquires Victory Pharma
Sciele will pay $150 million at closing for the privately-held U.S. pharmaceutical company
Cellerant Therapeutics begins innovative treatment
California based biotechnology company has developed an innovative hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer
Pharmaceutical companies and the swine flu virus
Many leading pharmaceutical companies are ready to step in with vaccines to curb the swine flu virus
GlaxoSmithKline PLC and Pfizer Inc. align to cure HIV
The two pharmaceutical giants set to work together to form a new, HIV treatment based company
Pharmaceuticals found in freshwater fish
Researchers say a number of fish caught near U.S. water treatment stations contain traces of pharmaceuticals
Shire and GlaxoSmithKline enter agreement to co-promote ADHD drug
The two pharmaceutical companies team up to promote Vyvanse, an ADHD improvement drug for adults
Pfizer to provide healthcare for China's poor
Along with non-profit PlaNet Finance, Pfizer plans to conduct research on the healthcare needs of the working poor in China
Scientists find a healthy use for tobacco
Researchers in Europe have produced genetically modified tobacco plants which may be able to cure type 1 diabetes
Merck gives malaria drug to non-profit group
Pharmaceutical company donates anti malarial candidate to the Medicines for Malaria Venture
Sepracor reaches deal with Teva Pharmaceutical over Xopenex
Sepracor say they have reached a settlement deal with Teva Pharmaceutical ending litigation over the drug Xopenex
Merck buys Schering-Plough for $41.1 billion
The two pharmaceutical giants merge under the Merck name
FDA charges KV Pharmaceutical Company for illegal activity
The Food and Drug Administration has filed a Consent Decree of permanent injunction against KV Pharmaceutical Company and its subsidiaries.
Watson Pharmaceuticals provides strong 4Q results
Leading US based pharmaceutical company posts strong 4Q and yearly total revenues
Oscient Pharmaceuticals goes through massive restructuring
Oscient Pharmaceuticals Corporation today announced a strategic realignment of its commercial organization
Doctors fear patients are not filling prescriptions
An Epocrates survey reveals 95 percent of physicians are worried its patients are not filling out prescriptions to cut costs
Pfizer will publicly disclose payments to U.S. Doctors
New York based pharmaceutical company will disclose payments to U.S. doctors for speaking engagements and consulting
Procter & Gamble looks to exit pharmaceuticals: report
Procter & Gamble Co (PG.N) is working with Goldman Sachs Group (GS.N) to identify potential buyers for its pharmaceuticals brands or find other ways to exit the business,
Pfizer nears deal to buy Wyeth
Pfizer Inc said Monday it will acquire rival U.S. drugmaker Wyeth for $68 billion (50 billion pounds) to soften the blow of losing its biggest product to generic competition, but a dividend cut and large debt financing concerned investors.
Pfizer and Wyeth talks intensify as boards meet
Pfizer Inc , the world's largest drugmaker, was close to a $68 billion (49.8 billion pound) purchase of U.S. rival Wyeth in a move to diversify its revenue base, sources familiar with the situation said on Sunday.
Pfizer reported in talks to buy Wyeth
Pfizer Inc, the world's largest drugmaker by revenue, is in talks to acquire rival Wyeth
Abbott opens research laboratory in Singapore
Abbott Laboratories said Tuesday, January 20, it has opened a pharmaceutical analytical research laboratory in Singapore, its first such research and development center in Southeast Asia.
Renovo names Blain CFO
Drug developer Renovo Group plc said Tuesday, January 20, it has appointed interim financial chief David Blain as its Chief Financial Officer and company secretary with effect from February 1.
Genentech profit up, forecast light
Genentech Inc on Thursday reported sales of its most closely watched drug, Avastin, that came in shy of expectations and disappointed investors with its 2009 earnings forecast, sending its shares lower.
Eli Lilly near $1.4 billion settlement: report
(Reuters) - Eli Lilly and Co is expected to agree as soon as Thursday to pay $1.4 billion to settle criminal and civil charges that it illegally marketed its antipsychotic drug Zyprexa for unauthorized use in patients vulnerable to its risky side effects, the New York Times said.
Roche confirms 2008 targets
Roche Holding AG confirmed its 2008 targets and said that it still expects a high single-digit increase in local currency sales and above market sales growth in both drugs and diagnostics units.
Cephalon signs option agreement to acquire Ception Therapeutics
Cephalon Inc said late Tuesday, January 14, that it has reached a deal with Ception Therapeutics Inc that allows it the option to acquire the privately-held firm for an upfront option payment of $100 million.
Hikma Pharma sees 30% 2008 revenue growth
London-listed generic drug maker Hikma Pharmaceuticals confirmed on Wednesday it expected sales to be up by about 30 percent in the year to end-December, with an operating performance in line with its expectations.
GSK seen as potential bidder for Aspen
South Africa's Aspen Pharmacare Holdings Ltd is a potential takeover target for GlaxoSmithKline plc, industry experts have said.
Pfizer says to cut 800 research jobs globally
Pfizer Inc , whose $7.5 billion annual research budget has produced few major medicines in recent years, said on Tuesday it would cut 800 research positions this year as part of a restructuring.
Glaxo signs early drug discovery deal with Biotica
GlaxoSmithKline has signed a three-year drug discovery deal with privately held biotech company Biotica Technology, giving the drugmaker access to Biotica's early-stage work in inflammatory diseases.
Roche preparing offer for Genentech
Reports suggest that the Swiss drugmaker is preparing a fresh offer for US biotechnology company Genentech.
Lilly fails to win FDA approval for Zyprexa
Eli Lilly & Co said it failed to win U.S. regulatory approval for its long-acting version of the antipsychotic drug Zyprexa.
AstraZeneca aims to sell flu vaccine in EU
AstraZeneca said its MedImmune biologics unit has submitted a marketing application for its nasal spray live attenuated influenza vaccine (LAIV) to the European Medicines Agency.
Pfizer eyes merger deal
Reports suggest that Pfizer, the world’s biggest pharmaceutical group, is considering acquiring a large rival drugs company to improve its financial health.
Biovail voluntarily recalls some lots of Ultram tablets
(Reuters) - Biovail Corp said it was voluntarily recalling certain lots of Ultram tablets, its treatment for chronic pain in adults, and expects the total cost related to the recall to hurt fourth-quarter Ultram revenues by $4.4 million.
Pfizer in talks to buy Wyeth: report
Pfizer will halve its dividend and raise $22 billion in debt to buy rival Wyeth for $68 billion in an acquisition aimed at softening the blow of losing its biggest product to generic competition.
Elan to review strategic business alternatives
Elan Corp has hired Citigroup Global Markets Inc to review the company’s strategic alternatives, which may include a merger or sale.
Elan announces strategy realignment
Elan Corp is to realign some of its functions to direct additional investment towards its innovative pipeline.
Merrion Pharmaceuticals enters agreement with Novo Nordisk
Irish research firm Merrion Pharmaceuticals has entered into an agreement with Novo Nordisk to develop and commercialise oral formulations of its diabetes drug.
Tysabri sales boost Elan’s Q3 revenue
Irish-based Elan Corp announced today, October 23, that total revenue soared 53 percent to US$270.1 million in the third quarter, driven by the growth of Tysabri.
AGI Therapeutics reports €8.9m pre-tax loss
The speciality pharmaceutical company AGI Therapeutics plc has reported pre-tax losses in the first-half of €8.9 million to the end of June.
Elan seeks quick sale of EDT
Elan Corp has received first-round bids for the drug delivery arm of its business, Elan Drug Technologies, and is hoping for a quick sale.
Elan revenues boosted by Tysabri sales
Elan Corp, the Irish drugmaker, said its first quarter financial results were boosted by sales of the MS drug Tysabri.
DIGITAL MAGAZINE
-
Free Subscription
-
Read Digital Magazine
-
View Publications
OTHER FEATURES
Hospitals
Nursing Homes
Medical Devices & Equipment
Pharmaceuticals
-
Free Subscription
-
Read Now
-
View Publications
-
Back Issues
Associations
and Events
Worldwide Medical Partners LLC
Worldwide Medical Partners can provide clients with significant savings on medical procedures while handling....
Lazard Capital Markets’ 6th Annual Healthcare Conference
November 17 - 18, 2009: New York, NY
Australasian College for Emergency Medicine 26th Annual Scientific Meeting
15-19 November 2009: Melbourne Convention and Exhibition Centre, Victoria, Australia
BIO-Europe Conference 2009
The 15th annual international partnering conference will be held November 2–4, 2009 in Vienna, Austria
Oppenheimer 20th Annual Healthcare Conference
The conference will be held November 3-4, 2009 at the Waldorf Astoria in New York City
-
Free Subscription
-
Read Now
-
View Publications
-
Back Issues
News and Information for Healthcare Executives
Exec Digital UK
Exec Digital USA
Exec Digital CA
Home
Healthcare News
Market Sectors
Hospitals
Nursing Homes
Medical Devices & Equipment
Pharmaceuticals
Blog
Corporate Profiles
Corporate Profiles
Back Issues
Newsletters
Other Industries
Construction
Energy
Manufacturing
Supply Chain
Healthcare
Stock Market
Retail
Technology
Food & Drink